Physician profile
Edward John Krowiak
NPI 1023018546
$5,294.71
in general payments reported to CMS, 2019-2025
23 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $1,676 · 2021: $493 · 2022: $418 · 2023: $154 · 2024: $281 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,575.00 | 2020 | |
| Stryker Corporation | $1,107.27 | 2019-2024 | Easy Clip |
| E.R. Squibb & Sons, L.L.C. | $581.26 | 2019 | |
| Depuy Synthes Sales INC. | $391.79 | 2019-2025 | Trumatch, Matrixmandible |
| Medtronic, INC. | $268.80 | 2021-2025 | Propel |
| Intuitive Surgical, INC. | $197.99 | 2019-2022 | |
| Ethicon US, LLC | $161.41 | 2019-2025 | Vistaseal |
| Optinose US, INC. | $130.03 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $127.72 | 2019-2020 | |
| Glaxosmithkline, LLC. | $117.72 | 2024 | Nucala |
| Cochlear Americas | $107.20 | 2021 | |
| Tactile Systems Technology INC | $105.28 | 2022 | |
| Karl Storz Endoscopy-America | $95.65 | 2019 | |
| Acclarent, INC | $73.72 | 2019-2023 | Trudi Nav Cable |
| Medical Device Business Services, INC. | $53.90 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $39.98 | 2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Genzyme Corporation | $31.17 | 2019-2021 | |
| Integra Lifesciences Corporation | $29.02 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $27.68 | 2019 | |
| Allergan, INC. | $23.82 | 2019 | |
| Abbvie INC. | $16.13 | 2019 | |
| Kaleo, INC. | $16.12 | 2020 | |
| Hospira, INC. | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Krowiak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.